BEAT News and Press, Heartbeam Inc.

2026-06-30 10:35:00 ET Advances in digital health, cloud computing and data analytics are making it possible to move beyond episodic monitoring toward a more comprehensive understanding of cardiovascular health. HeartBeam’s proprietary HeartBeam System reflects the company ...

2026-06-30 09:35:00 ET HeartBeam (NASDAQ: BEAT) announced it has completed patient enrollment ahead of schedule in its ALIGN-ACS pilot study evaluating the HeartBeam System for heart attack detection. The study enrolled 120 patients presenting with chest pain at two clinical sites in Be...

Accelerated enrollment completion in ALIGN-ASS study underscores HeartBeam’s execution on its key strategic priority of heart attack detection Data analysis is underway, with full results anticipated for presentation at upcoming cardiology conference Findings will inform th...

2026-06-25 09:24:30 ET HeartBeam (NASDAQ: BEAT) announced a strategic reorganization aimed at accelerating execution, expanding global market reach and improving capital efficiency as it advances commercialization of its cardiac monitoring technology. Under the new structure, Founder an...

Company will license its 3D ECG signal technology to established partners, moving beyond direct medical device sales Advancing toward heart attack detection as a key expansion of the platform Tailoring its technology to fit each market, while operating with a leaner, more focused ...

2026-06-22 09:05:00 ET The seriousness of coronary artery disease continues to intensify as populations age and cardiovascular risk factors become more common. HeartBeam announced the launch of a pilot study focused on evaluating its on-demand 12-lead ECG patch in detecting coronary a...

2026-06-02 09:05:00 ET HeartBeam (NASDAQ: BEAT) a medical technology company focused on transforming cardiac care by providing powerful cardiac insights, announced that a peer-reviewed article in JACC: Advances demonstrated that a risk prediction algorithm incorporating the credit card-...

Publication in JACC: Advances demonstrates that an algorithm combining the HeartBeam ECG device with patient risk factors and symptoms can accurately identify heart attack risk Study advances the scientific foundation supporting HeartBeam's planned indication expansion into heart attack d...

2026-05-22 15:34:53 ET HeartBeam (NASDAQ: BEAT) is developing technology aimed at improving how cardiac conditions are identified and monitored, positioning its solutions at the intersection of rising clinical need and evolving innovation. “One of the most persistent challenges i...

2026-05-22 07:15:03 ET H.C. Wainwright analyst issues BUY recommendation for BEAT on May 22, 2026 10:50AM ET. The previous analyst recommendation was Buy. BEAT was trading at $0.9205 at issue of the analyst recommendation. The overall analyst consensus : BUY. Current...